can tirzepatide cause allodynia In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients GLP-1 Drugs: New Reports of

Sergey Terushkin, MD, FACS The honest answer is yesbut only for some patients

The recommended dose is 5 mcg twice daily initially, which may be increased to 10 mcg twice daily after one month based on clinical response and tolerability

In clinical trials for Contrave, between 36% and 57% of people (depending on which study) lost 5% or more of body weight, and 15% to 35% of people lost 10% or more

Another point of consideration involves renal function

Melanocortin Receptor Profile Human Research Findings Pigmentation First, the pilot human study reported measurable skin darkening after repeated subcutaneous administration

These investigations help clarify how integrated incretin and glucagon signaling contributes to the regulation of metabolic energy flux in complex biological systems